[26P2-pm2] Pharmaceutics

[26P2-pm2-079S] Neuroprotective effects in the brain by intranasal edaravone of improved solubility with PEG

○Natsumi Hosoda¹, Mitsuyoshi Fukuda², Keisuke Yanagihara¹, Taiki Nagatomo¹, Naoto Suzuki¹, Nobuhiro Nishimura², Yasuo Kizawa¹, Toyofumi Suzuki¹ (1. Sch. Pharm., Nihon Univ., 2. Sch. Pharm. at Fukuoka, International University of Health and Welfare)